THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 95 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 28.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,496 | +9.4% | 6,083 | +31.2% | 0.00% | 0.0% |
| Q2 2023 | $47,993 | -4.6% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,311 | -0.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $50,543 | +7.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $47,000 | +11.9% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $42,000 | -4.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $44,000 | -13.7% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $51,000 | +82.1% | 4,637 | +22.2% | 0.00% | +100.0% |
| Q3 2021 | $28,000 | -49.1% | 3,794 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $55,000 | -28.6% | 3,794 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $77,000 | +1.3% | 3,794 | -11.4% | 0.00% | 0.0% |
| Q4 2020 | $76,000 | +20.6% | 4,282 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $63,000 | -30.0% | 4,282 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $90,000 | -2.2% | 4,282 | +7.8% | 0.00% | -20.0% |
| Q1 2020 | $92,000 | -3.2% | 3,972 | +8.3% | 0.01% | +25.0% |
| Q4 2019 | $95,000 | +33.8% | 3,666 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $71,000 | +18.3% | 3,666 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $60,000 | -27.7% | 3,666 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $83,000 | -11.7% | 3,666 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $94,000 | -21.7% | 3,666 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $120,000 | +44.6% | 3,666 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $83,000 | -6.7% | 3,666 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $89,000 | -40.7% | 3,666 | -5.1% | 0.00% | -42.9% |
| Q4 2017 | $150,000 | +20.0% | 3,865 | 0.0% | 0.01% | +16.7% |
| Q3 2017 | $125,000 | -18.3% | 3,865 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $153,000 | +15.0% | 3,865 | +6.3% | 0.01% | 0.0% |
| Q1 2017 | $133,000 | +1800.0% | 3,635 | +1494.3% | 0.01% | – |
| Q4 2016 | $7,000 | -12.5% | 228 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +60.0% | 228 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 228 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | +33.3% | 228 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |